Clinical Trials on Primary Sjögren's Syndrome (pSS)

Total 10523 results

Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
University Hospital, Strasbourg, France

Completed

Efficacy of Tocilizumab in Primary Sjögren's Syndrome. (ETAP)

Primary Sjögren's Syndrome (pSS)

France
University Hospital, Brest

Recruiting

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort (DIApSS)

Primary Sjögren's Syndrome (pSS)

France
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome (pSS)

Korea, Republic of
Horizon Pharma Ireland, Ltd., Dublin Ireland

Recruiting

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Sjögren's Syndrome (SS)

United States
Akdeniz University

Completed

Pelvic Floor Exercises in Patients With Sjögren's

Sjögren Syndrome | Sjögren

Turkey
argenx
Iqvia Pty Ltd

Recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
Peking University People's Hospital

Recruiting

Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome

Primary Sjögren's Syndrome

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Assistance Publique - Hôpitaux de Paris
Societe Francaise de Rhumatologie

Recruiting

The ASSESS National Multi-center Prospective Cohort (ASSESS)

Primary Sjögren's Syndrome

France
RemeGen Co., Ltd.

Completed

A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
National Institute of Allergy and Infectious Diseases...
Biogen; Autoimmunity Centers of Excellence

Terminated

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Primary Sjögren's Syndrome

United States
Novartis Pharmaceuticals

Withdrawn

Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome
argenx
Iqvia Pty Ltd

Active, not recruiting

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (rho)

Primary Sjögren's Syndrome

Belgium, Poland, Hungary, Netherlands
Bristol-Myers Squibb

Terminated

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome

Healthy Participants | Primary Sjögren's Syndrome

Germany, United States
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

Hungary, Germany
UCB Celltech
PRA Health Sciences

Terminated

UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

France, Italy, Spain, Sweden, United Kingdom
MedImmune LLC
Amgen

Completed

A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Sweden, France, United Kingdom
University Hospital, Limoges

Completed

Primary Sjögren Syndrome (NeuroSenSS)

Primary Sjögren's Syndrome

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity (I GET DRY)

Primary Sjögren's Syndrome

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Primary Sjögren's Syndrome

United States, France, United Kingdom, Australia, Germany, Hungary, Spain
Novartis Pharmaceuticals

Completed

PD of VAY736 in Patients With Primary Sjögren's Syndrome (CVAY736X2201)

Primary Sjögren's Syndrome

Germany
Incyte Corporation

Completed

A Study of INCB050465 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States
Novartis Pharmaceuticals

Completed

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Hungary, Germany, Switzerland, United Kingdom
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Assistance Publique - Hôpitaux de Paris
Sanofi

Completed

Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome (JOQUER)

Primary Sjögren's Syndrome

France
Gazi University

Not yet recruiting

The Profile of Fatigue and Discomfort - Sicca Symptoms Inventory

Primary Sjögren's Syndrome

Turkey
University Hospital, Strasbourg, France

Recruiting

Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies (TINISS)

Primary Sjögren's Syndrome Painful Sensory Neuropathies

France
Biogen

Completed

A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome

Healthy | Sjögren's Syndrome | Sicca Syndrome

United States
University Hospital, Brest

Unknown

Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease (MASAÏ)

Primary sjögren's Syndrome

France
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome

China
University of Copenhagen
Rigshospitalet, Denmark; ITI Foundation; Gigtforeningen

Completed

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

Dental Implant | Primary Sjögren Syndrome
University of Rochester

Completed

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

Primary Sjögren Syndrome

United States
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Sjögren's Syndrome

United States, Australia, Germany, Austria, China, Korea, Republic of, Puerto Rico, Poland, Japan, Canada, Hungary, Spain, Argentina, Chile, Denmark, France, Italy, Mexico, Peru, Taiwan, Netherlands, Belgium, Brazil, Colombia, United Kingdom and more
University Medical Center Groningen
Bristol-Myers Squibb

Completed

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAPIII)

Sjögren's Syndrome

Netherlands
National Institute of Dental and Craniofacial Research...

Terminated

Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects

Xerostomia | Sjögren's Syndrome

United States
Gazi University

Recruiting

Reliability, Validity of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire

Primary Sjögren's Syndrome

Turkey
Rise Therapeutics LLC

Not yet recruiting

R-2487 in Patients With Sjogren's Syndrome (SS) (R-2487-SS-01)

Sjogren's Syndrome | Sjögren | Sjögren Syndrome, Unspecified
AbbVie

Withdrawn

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Sjogren's Syndrome (SS)

Netherlands
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Peking University People's Hospital

Recruiting

Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome

Sjögren's Syndrome

China
Amgen

Completed

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome

United States, France, Italy, Hungary, Poland, Argentina, India, Korea, Republic of, Mexico, Peru, Taiwan, United Kingdom
Sanofi

Completed

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Sjogren's Syndrome | Sjögren's Syndrome

Belgium, Taiwan, Korea, Republic of, United States, Argentina, Canada, Chile, France, Germany, Hungary, Mexico, Spain
Taipei Veterans General Hospital, Taiwan

Unknown

DNA Exome Sequencing TCM for Sjögren's Syndrome

Sjögren's Syndrome

Taiwan
University of California, Los Angeles
University Medical Center Groningen; Oklahoma Medical Research Foundation

Completed

Salivary Biomarkers for Sjögren's Syndrome Detection

Sjögren's Syndrome

United States
Derk Jan Jager

Unknown

Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome

Sjögren's Syndrome

Netherlands
Ankara Education and Research Hospital

Completed

Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions

Primary Sjögren Syndrome

Turkey
University Hospital, Brest

Unknown

Eye Dryness Evaluation in Primary Sjögren's Syndrome (PEPSS)

Primary Sjögren Syndrome

Clinical Trials on Primary Sjögren's Syndrome (pSS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations